ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study.

Hao Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.